These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 15269253)

  • 41. Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF.
    Bensadoun JC; Déglon N; Tseng JL; Ridet JL; Zurn AD; Aebischer P
    Exp Neurol; 2000 Jul; 164(1):15-24. PubMed ID: 10877911
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's disease.
    Wang L; Muramatsu S; Lu Y; Ikeguchi K; Fujimoto K; Okada T; Mizukami H; Hanazono Y; Kume A; Urano F; Ichinose H; Nagatsu T; Nakano I; Ozawa K
    Gene Ther; 2002 Mar; 9(6):381-9. PubMed ID: 11960314
    [TBL] [Abstract][Full Text] [Related]  

  • 43. GDNF reduces drug-induced rotational behavior after medial forebrain bundle transection by a mechanism not involving striatal dopamine.
    Tseng JL; Baetge EE; Zurn AD; Aebischer P
    J Neurosci; 1997 Jan; 17(1):325-33. PubMed ID: 8987758
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The vigilance-promoting drug modafinil counteracts the reduction of tyrosine hydroxylase immunoreactivity and of dopamine stores in nigrostriatal dopamine neurons in the male rat after a partial transection of the dopamine pathway.
    Ueki A; Rosén L; Andbjer B; Finnman UB; Altamimi U; Janson AM; Goldstein M; Agnati LF; Fuxe K
    Exp Brain Res; 1993; 93(2):259-70. PubMed ID: 8098283
    [TBL] [Abstract][Full Text] [Related]  

  • 45. GDNF protection against 6-OHDA-induced reductions in potassium-evoked overflow of striatal dopamine.
    Cass WA; Manning MW
    J Neurosci; 1999 Feb; 19(4):1416-23. PubMed ID: 9952418
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term restoration of nigrostriatal system function by implanting GDNF genetically modified fibroblasts in a rat model of Parkinson's disease.
    Duan D; Yang H; Zhang J; Zhang J; Xu Q
    Exp Brain Res; 2005 Mar; 161(3):316-24. PubMed ID: 15480595
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glial cell line-derived neurotrophic factor attenuates behavioural deficits and regulates nigrostriatal dopaminergic and peptidergic markers in 6-hydroxydopamine-lesioned adult rats: comparison of intraventricular and intranigral delivery.
    Lapchak PA; Miller PJ; Collins F; Jiao S
    Neuroscience; 1997 May; 78(1):61-72. PubMed ID: 9135089
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reversible neurochemical changes mediated by delayed intrastriatal glial cell line-derived neurotrophic factor gene delivery in a partial Parkinson's disease rat model.
    Yang X; Mertens B; Lehtonen E; Vercammen L; Bockstael O; Chtarto A; Levivier M; Brotchi J; Michotte Y; Baekelandt V; Sarre S; Tenenbaum L
    J Gene Med; 2009 Oct; 11(10):899-912. PubMed ID: 19639608
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fetal intra-nigral ventral mesencephalon and kidney tissue bridge transplantation restores the nigrostriatal dopamine pathway in hemi-parkinsonian rats.
    Chiang Y; Morales M; Zhou FC; Borlongan C; Hoffer BJ; Wang Y
    Brain Res; 2001 Jan; 889(1-2):200-7. PubMed ID: 11166704
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhanced nigrostriatal neuron-specific, long-term expression by using neural-specific promoters in combination with targeted gene transfer by modified helper virus-free HSV-1 vector particles.
    Cao H; Zhang GR; Wang X; Kong L; Geller AI
    BMC Neurosci; 2008 Apr; 9():37. PubMed ID: 18402684
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Promotion of survival and regeneration of nigral dopamine neurons in a rat model of Parkinson's disease after implantation of embryonal carcinoma-derived neurons genetically engineered to produce glial cell line-derived neurotrophic factor.
    Nakao N; Yokote H; Nakai K; Itakura T
    J Neurosurg; 2000 Apr; 92(4):659-70. PubMed ID: 10761657
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adeno-associated viral delivery of GDNF promotes recovery of dopaminergic phenotype following a unilateral 6-hydroxydopamine lesion.
    McGrath J; Lintz E; Hoffer BJ; Gerhardt GA; Quintero EM; Granholm AC
    Cell Transplant; 2002; 11(3):215-27. PubMed ID: 12075987
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term protection of the rat nigrostriatal dopaminergic system by glial cell line-derived neurotrophic factor against 6-hydroxydopamine in vivo.
    Sullivan AM; Opacka-Juffry J; Blunt SB
    Eur J Neurosci; 1998 Jan; 10(1):57-63. PubMed ID: 9753113
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adenoviral vector-mediated delivery of glial cell line-derived neurotrophic factor provides neuroprotection in the aged parkinsonian rat.
    Connor B
    Clin Exp Pharmacol Physiol; 2001 Nov; 28(11):896-900. PubMed ID: 11703392
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functional reinnervation from remaining DA terminals induced by GDNF lentivirus in a rat model of early Parkinson's disease.
    Brizard M; Carcenac C; Bemelmans AP; Feuerstein C; Mallet J; Savasta M
    Neurobiol Dis; 2006 Jan; 21(1):90-101. PubMed ID: 16084732
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis, protein levels, activity, and phosphorylation state of tyrosine hydroxylase in mesoaccumbens and nigrostriatal dopamine pathways of chronically food-restricted rats.
    Pan Y; Berman Y; Haberny S; Meller E; Carr KD
    Brain Res; 2006 Nov; 1122(1):135-42. PubMed ID: 17010321
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adenoviral vector-mediated GDNF gene therapy in a rodent lesion model of late stage Parkinson's disease.
    Lapchak PA; Araujo DM; Hilt DC; Sheng J; Jiao S
    Brain Res; 1997 Nov; 777(1-2):153-60. PubMed ID: 9449424
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nigral GFRα1 infusion in aged rats increases locomotor activity, nigral tyrosine hydroxylase, and dopamine content in synchronicity.
    Pruett BS; Salvatore MF
    Mol Neurobiol; 2013 Jun; 47(3):988-99. PubMed ID: 23321789
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Continuous exposure to glial cell line-derived neurotrophic factor to mature dopaminergic transplants impairs the graft's ability to improve spontaneous motor behavior in parkinsonian rats.
    Winkler C; Georgievska B; Carlsson T; Lacar B; Kirik D
    Neuroscience; 2006 Aug; 141(1):521-31. PubMed ID: 16697115
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Striatal expression of GDNF and differential vulnerability of midbrain dopaminergic cells.
    Barroso-Chinea P; Cruz-Muros I; Aymerich MS; Rodríguez-Díaz M; Afonso-Oramas D; Lanciego JL; González-Hernández T
    Eur J Neurosci; 2005 Apr; 21(7):1815-27. PubMed ID: 15869477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.